Literature DB >> 18622293

Human fibroblasts are permissive for porcine cytomegalovirus in vitro.

Jennifer L Whitteker1, Anil K Dudani, Eilleen S Tackaberry.   

Abstract

BACKGROUND: Xenotransplantation with pig organs is being considered to alleviate donor organ shortages; however, the risk of introducing porcine viruses into humans is heightened in this setting. The goal of this study was to determine the infectious potential of porcine cytomegalovirus (PCMV), a xenozoonotic virus of interest, in human fibroblasts in vitro.
METHODS: Confluent human cells were incubated with live PCMV, heat-killed PCMV, or medium alone. Infection was investigated by testing for viral-induced cytopathic effect, assaying viral transcription by nested RT-PCR and subsequent sequencing, and detecting viral protein expression by Western blotting. Plaque neutralization experiments were also performed.
RESULTS: Cells incubated with PCMV demonstrated significant cytopathic effect by 7 days postinfection, and reverse-transcriptase polymerase chain reaction sequencing identified PCMV DNA polymerase in these infected cells. In Western blots, monoclonal antibodies (mAbs) to human CMV glycoprotein B and pig serum presumed to contain anti-PCMV antibodies detected characteristic proteins in experimentally infected human cells and positive controls but not in negative controls. Furthermore, one of these mAbs and the pig serum neutralized PCMV infection in vitro.
CONCLUSIONS: These results are a first demonstration that PCMV can infect human fibroblasts in vitro.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18622293     DOI: 10.1097/TP.0b013e31817d4823

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  14 in total

1.  Establishment of rat brain endothelial cells susceptible to rat cytomegalovirus ALL-03 infection.

Authors:  Siti-Nazrina Camalxaman; Nazariah Allaudin Zeenathul; Yi-Wan Quah; Hwei-San Loh; Hassan Zuridah; Homayoun Hani; Abdul Rahman Sheikh-Omar; Mohd Lila Mohd-Azmi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-02-22       Impact factor: 2.416

Review 2.  Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses.

Authors:  Joachim Denner; Ralf R Tönjes
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

3.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

4.  Efficient replication of rhesus cytomegalovirus variants in multiple rhesus and human cell types.

Authors:  Anders E Lilja; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-08       Impact factor: 11.205

5.  Effective Detection of Porcine Cytomegalovirus Using Non-Invasively Taken Samples from Piglets.

Authors:  Vladimir A Morozov; Gerd Heinrichs; Joachim Denner
Journal:  Viruses       Date:  2017-01-12       Impact factor: 5.048

6.  Antibody Cross-Reactivity between Porcine Cytomegalovirus (PCMV) and Human Herpesvirus-6 (HHV-6).

Authors:  Uwe Fiebig; Angela Holzer; Daniel Ivanusic; Elena Plotzki; Hartmut Hengel; Frank Neipel; Joachim Denner
Journal:  Viruses       Date:  2017-10-28       Impact factor: 5.048

Review 7.  Xenotransplantation - A special case of One Health.

Authors:  Joachim Denner
Journal:  One Health       Date:  2017-02-09

Review 8.  Reduction of the survival time of pig xenotransplants by porcine cytomegalovirus.

Authors:  Joachim Denner
Journal:  Virol J       Date:  2018-11-08       Impact factor: 4.099

9.  Identification and Analysis of the Porcine MicroRNA in Porcine Cytomegalovirus-Infected Macrophages Using Deep Sequencing.

Authors:  Xiao Liu; Shan Liao; Zhiwen Xu; Ling Zhu; Fan Yang; Wanzhu Guo
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240

10.  Distribution of Porcine Cytomegalovirus in Infected Donor Pigs and in Baboon Recipients of Pig Heart Transplantation.

Authors:  Uwe Fiebig; Jan-Michael Abicht; Tanja Mayr; Matthias Längin; Andrea Bähr; Sonja Guethoff; Almuth Falkenau; Eckhard Wolf; Bruno Reichart; Tomoyuki Shibahara; Joachim Denner
Journal:  Viruses       Date:  2018-02-06       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.